Current price
Description
Return
Here you can see the performance (incl. distributions) of the L&G Pharma Breakthrough UCITS ETF.
| Period | Performance |
|---|---|
| 1 Week | -3.54 % |
| 1 Month | +3.03 % |
| 3 Months | -4.27 % |
| 6 Months | +12.33 % |
| 1 Year | +8.96 % |
| 3 Years | +39.03 %(11.61 % p.a.) |
| 5 Years | +14.65 %(2.77 % p.a.) |
| 10 Years | — |
| Since inception | +56.70 %(5.22 % p.a.) |
| Year | Performance |
|---|---|
| YTD | +9.84 % |
| 2025 | +20.62 % |
| 2024 | +1.55 % |
| 2023 | -13.30 % |
| 2022 | -1.19 % |
| 2021 | +3.45 % |
Master data
Key master data for the L&G Pharma Breakthrough UCITS ETF
| Total expense ratio (TER) | 0.49 % |
| Index replication | Physical |
| Replication method | Full |
| Distribution policy | Accumulating |
| Fund size | £17.97M |
| Fund launch | 18 Jan 2018 |
| Fund currency | USD |
| Currency hedging | No |
| Fund domicile | Irland |
Risk indicator (SRI) | 4 · medium risk class |
Risk metrics
Key risk and analysis metrics for the L&G Pharma Breakthrough UCITS ETF
Volatility | 16.35 % 1 Year 15.31 % 3 Years 14.33 % 5 Years |
max. Drawdown | -5.08 % 1 Year -11.34 % 3 Years -28.07 % 5 Years |
Sharpe Ratio | 0.65 1 Year 0.82 3 Years 0.02 5 Years |
XLM | 49.60 |
Information about the Solactive Pharma Breakthrough V NR USD Index
| Index name | Solactive Pharma Breakthrough V NR USD (1) |
| Included securities | 44 |
| Stock positions | 40 |
| Bond positions | 0 |
| Cash and other positions | 4 |
More ETFs tracking the Solactive Pharma Breakthrough V NR USD Index
Here you can find alternative index funds for the Solactive Pharma Breakthrough V NR USD.
| Fund name | WKN | TER |
|---|---|---|
| No results |
Frequently asked questions
Here you will find all answers to your questions about the L&G Pharma Breakthrough UCITS ETF
Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).
Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.
Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.